Joseph Tuma, MD
Interventional Cardiology · Rapid City, SDNPI 1326081225
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 87.3% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $15,870 and has fallen 74.5% since, to $4,055 in 2025.
Across 434 payments — averaging $140.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$53K
- Abbott$3K
- Edwards Lifesciences$2K
- Boston Scientific$766
- Endologix LLC$598
- Bard Peripheral Vascular, Inc.$305
- plus $2K from 21 others
Across 51 payments — averaging $1816.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$39K
- Bayer$34K
- Microvention, Inc.$13K
- Daiichi Sankyo Inc.$4K
- Contego Medical, Inc$3K
- Boston Scientific$133
What the payments were for
- Speaking & faculty fees$31,62552%
- Travel & lodging$13,43822%
- Food & beverage$16,05026%
- Education$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 233 | $53,381 |
| Abbott | 39 | $2,513 |
| Edwards Lifesciences | 18 | $1,573 |
| Boston Scientific | 30 | $766 |
| Endologix LLC | 3 | $598 |
| Bard Peripheral Vascular, Inc. | 17 | $305 |
| W. L. Gore & Associates, Inc. | 10 | $297 |
| Inspiremd Ltd | 3 | $250 |
| Abiomed | 7 | $230 |
| Johnson & Johnson | 28 | $222 |
| Chiesi USA, Inc. | 16 | $179 |
| Pfizer | 6 | $150 |
| Merck | 1 | $113 |
| Biosense Webster, Inc. | 1 | $108 |
| Philips North America LLC | 2 | $95 |
| Atricure, Inc. | 1 | $80 |
| Novartis | 4 | $52 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $50 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Cardiovascular Systems Inc. | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 2 | $25 |
| Amgen | 2 | $24 |
| Angiodynamics, Inc. | 1 | $22 |
| Teleflex LLC | 1 | $17 |
| Biotronik Inc. | 1 | $14 |
| Silk Road Medical, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$20,730
- CoreValve Evolut$15,725
- Resolute$7,534
- TRAcelet$1,511
- TurboHawk$1,218
- TRICLIP$1,185
- Ovation iX Iliac Stent Graft$326
- Ovation$272
- SAPIEN 3 Ultra RESILIA$239
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$231
- WATCHMAN FLX$125
- IN.PACT Admiral$121
- CGuard Prime Carotid Stent System$120
- Perclose ProGlide suture mediated closure system$117
- PRESSUREWIRE$115
- WINREVAIR$113
- General - Balloon Catheters$111
- CardioMEMS HF System$110
- Carto 3$108
- HawkOne$102
How this compares
Too few interventional cardiology providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 13 | $21,761 |
| EliquisApixaban | 29 | $16,658 |
| Praluent PenAlirocumab | 11 | $10,116 |
| ClopidogrelClopidogrel Bisulfate | 145 | $1,564 |
| Carvedilol | 65 | $471 |
| Atorvastatin Calcium | 85 | $436 |
| Prasugrel Hcl | 11 | $419 |
| Warfarin Sodium | 48 | $276 |
| Amlodipine Besylate | 38 | $249 |
| Metoprolol Succinate | 32 | $211 |
| Lisinopril | 11 | $131 |
| Losartan Potassium | 24 | $101 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $61 |
| Furosemide | 19 | $37 |
| Prednisone | 20 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $222 | $21,76113 claims |
| PfizerEliquis | $150 | $16,65829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few interventional cardiology providers in South Dakotaon file to place this against a meaningful peer group, so we don't.
Other interventional cardiology in Rapid City
- Thomas WilsonRapid City$18K
- John WagenerSioux Falls$36K
- Joseph ElliottWatertown$14K
- Sean HalliganSioux Falls$12K
- Tomasz StysSioux Falls$9K
- Adam StysSioux Falls$7K
- Marian PetraskoSioux Falls$4K
- Ravishankar KalagaWatertown$4K
- Salem MaalikiWatertown$2K
- Thomas WaterburySioux Falls$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.